Cargando…

Elevated Incidence of Fractures in Solid-Organ Transplant Recipients on Glucocorticoid-Sparing Immunosuppressive Regimens

This study was conducted to assess the occurrence of fractures in solid-organ transplant recipients. Methods. Medical record review and surveys were performed. Patients received less than 6 months of glucocorticoids. Results. Of 351 transplant patients, 175 patients provided fracture information, wi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Edwards, B. J., Desai, A., Tsai, J., Du, H., Edwards, G. R., Bunta, A. D., Hahr, A., Abecassis, M., Sprague, S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE-Hindawi Access to Research 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3172972/ https://www.ncbi.nlm.nih.gov/pubmed/21922049 http://dx.doi.org/10.4061/2011/591793

Ejemplares similares

Evidence for the Immunosuppressive Potential of Calcineurin Inhibitor-Sparing Regimens in Liver Transplant Recipients with Impaired Renal Function
por: Ide, Kentaro, et al.
Publicado: (2011)

Evolving concepts in the selection of immunosuppression regimen for liver transplant recipients
por: Locke, Jayme E, et al.
Publicado: (2011)

Enhancing Beta Cell Replacement Therapies: Exploring Calcineurin Inhibitor-Sparing Immunosuppressive Regimens
por: Caldara, Rossana, et al.
Publicado: (2023)

Belatacept-based immunosuppressive regimen in HIV-positive kidney transplant recipients
por: El Sakhawi, Karim, et al.
Publicado: (2020)

Immunosuppressive regimens on conversion of cytomegalovirus infection to disease in liver transplant recipients
por: Rabbani, Amirhassan, et al.
Publicado: (2022)

Renal Outcomes of Liver Transplantation Recipients Receiving Standard Immunosuppression and Early Renal Sparing Immunosuppression: A Retrospective Single Center Study
por: Sharma, Pratima, et al.
Publicado: (2019)

Comparison of the Immune Response After an Extended Primary Series of COVID-19 Vaccination in Kidney Transplant Recipients Receiving Standard Versus Mycophenolic Acid–sparing Immunosuppressive Regimen
por: Phirom, Supitchaya, et al.
Publicado: (2022)

Drug Interactions between Antimicrobial and Immunosuppressive Agents in Solid Organ Transplant Recipients
por: Bhagat, Vikas, et al.
Publicado: (2021)

Histological spectrum of pulmonary manifestations in kidney transplant recipients on sirolimus inclusive immunosuppressive regimens
por: Kirby, Sean, et al.
Publicado: (2012)

Tailored long-term immunosuppressive regimen for adult liver transplant recipients with hepatocellular carcinoma
por: Kang, Sung-Hwa, et al.
Publicado: (2014)

Cost utility analysis of immunosuppressive regimens in adult renal transplant recipients in England and Wales
por: Muduma, Gorden, et al.
Publicado: (2014)

COVID-19 Hospitalization in Solid Organ Transplant Recipients on Immunosuppressive Therapy
por: Kolla, Epiphane, et al.
Publicado: (2023)

Impact of immunosuppression on incidence of post-transplant diabetes mellitus in solid organ transplant recipients: Systematic review and meta-analysis
por: Kotha, Sreelakshmi, et al.
Publicado: (2021)

Impact of immunosuppressive therapy on the severity of COVID-19 in solid organ transplant recipients
por: Merli, Marco, et al.
Publicado: (2021)

Risk factors and outcomes of delayed graft function in renal transplant recipients receiving a steroid sparing immunosuppression protocol
por: Willicombe, Michelle, et al.
Publicado: (2017)

Nocardiosis and elevated beta-d-glucan in solid organ transplant recipients
por: Ringer, Matthew, et al.
Publicado: (2021)

Longitudinal evaluation of the impact of immunosuppressive regimen on immune responses to COVID-19 vaccination in kidney transplant recipients
por: Wiedemann, Aurélie, et al.
Publicado: (2022)

Tailoring management and immunosuppression regimen in kidney transplant recipients with COVID-19 infection: lessons from Singapore
por: Chang, Zi Yun, et al.
Publicado: (2021)

Long‐Term Corticosteroid‐Sparing Immunosuppression for Cardiac Sarcoidosis
por: Rosenthal, David G., et al.
Publicado: (2019)

Acyclovir-resistant herpetic keratitis in a solid-organ transplant recipient on systemic immunosuppression
por: Turner, Liam Daniel, et al.
Publicado: (2013)

Abstract 58: Favourable outcomes with therapeutic glucocorticoid regimen compared to replacement glucocorticoid regimen in primary hypophysitis
por: Das, Liza, et al.
Publicado: (2022)

(1078) The Antibody Response of an MMF-Containing Immunosuppressive Regimen Aftercovid-19 Vaccination in Asian Heart Transplant Recipient
por: Tsao, C., et al.
Publicado: (2023)

1092. Management of Transplant Graft and Role of Immunosuppression in the Outcome of Covid-19 Infection in Solid Organ Transplant Recipients
por: Sabunwala, Suhel A, et al.
Publicado: (2022)

Reduced incidence of pneumonia in influenza‐vaccinated solid organ transplant recipients with influenza disease
por: Perez‐Romero, P., et al.
Publicado: (2012)

Incidence and Outcomes Associated With Clostridioides difficile Infection in Solid Organ Transplant Recipients
por: Hosseini-Moghaddam, Seyed M., et al.
Publicado: (2021)

Intervention of PKC-θ as an immunosuppressive regimen
por: Sun, Zuoming
Publicado: (2012)

Outcomes of Liver Transplant Recipients With Autoimmune Liver Disease Using Long-Term Dual Immunosuppression Regimen Without Corticosteroid
por: Satapathy, Sanjaya K., et al.
Publicado: (2017)

Efficacy and Safety of Iguratimod Supplement to the Standard Immunosuppressive Regimen in Highly Mismatched Renal Transplant Recipients: A Pilot Study
por: Tao, Jun, et al.
Publicado: (2021)

Immunosuppressive regimens for adult liver transplant recipients in real-life practice: consensus recommendations from an Italian Working Group
por: Cillo, Umberto, et al.
Publicado: (2020)

Patient involvement in selection of immunosuppressive regimen following transplantation
por: Popoola, Joyce, et al.
Publicado: (2014)

Sparing of Severe Covid-19 in Vaccinated Adolescents
por: Edwards, Kathryn M.
Publicado: (2022)

Daratumumab-based Regimen in Treating Clonal Plasma Cell Neoplasms in Solid Organ Transplant Recipients
por: Chaulagain, Chakra P., et al.
Publicado: (2020)

Eosinophilic Pustular Folliculitis: Association with Long-Term Immunosuppressant Use in a Solid Organ Transplant Recipient
por: Kim, Byung Wook, et al.
Publicado: (2014)

Revision of immunosuppression in a solid organ transplant recipient leads to complete remission of metastatic undifferentiated carcinoma
por: Waldman, Abigail H., et al.
Publicado: (2015)

Tumors recycle glucocorticoids to drive Treg-mediated immunosuppression
por: Swatler, Julian, et al.
Publicado: (2023)

Correction to: Immunosuppressive regimens for adult liver transplant recipients in real-life practice: consensus recommendations from an Italian Working Group
por: Cillo, Umberto, et al.
Publicado: (2021)

Impact of immunosuppression regimen on COVID-19 mortality in kidney transplant recipients: Analysis from a Colombian transplantation centers registry
por: Montero, Camilo, et al.
Publicado: (2022)

Peripheral blood and bronchoalveolar leukocyte profile in lung transplant recipients and their changes according to immunosuppressive regimen: A single‐center experience
por: Jáky‐Kováts, Zsuzsanna, et al.
Publicado: (2022)

Impact of immunosuppression regimen on COVID-19 mortality in kidney transplant recipients: Analysis from a Colombian transplantation centers registry
por: Montero, Camilo, et al.
Publicado: (2023)

BK Virus in Kidney Transplant Recipients: The Influence of Immunosuppression
por: Barraclough, Katherine A., et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_mch32i82hc1s7o81797lrgdd0j